Context: Caesarean section performed under subarachnoid block is often accompanied by visceral pain. Hence, various adjuvants have been tried to address this problem and to provide prolonged post-operative analgesia. Highly selective α2-agonist dexmedetomidine is increasingly used as an intrathecal adjuvant.
Aims: The study was designed to evaluate dexmedetomidine 5µg as adjuvant to intrathecal hyperbaric 0.5% bupivacaine 9mg in caesarean sections with respect to block characteristics, sedation and neonatal APGAR scores.
Settings and Design: A prospective, randomised, double blinded, controlled study
Methods and Material: 60 parturients undergoing elective lower segment caesarean section were assigned to 2 groups (n=30) to receive either 0.5% hyperbaric bupivacaine 9 mg with dexmedetomidine 5 µg (Group D) or 0.5% hyperbaric bupivacaine 9 mg with saline (Group C).
Statistical analysis used: Data obtained were compiled and analysed with appropriate tests. A p-value of
Key words: Caesarean section; Intrathecal; Dexmedetomidine; Hyperbaric bupivacaine; Spinal anaesthesia
|
